drugset / Trial / NCT00418119

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

NCT00418119

Phase 4 Unknown 10 enrolled Rabin Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

Timeline

Start
2007-01
Primary completion
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic

Indications